Literature DB >> 20110114

An unbiased prospective report of perioperative complications of robot-assisted laparoscopic radical prostatectomy.

Michael S Lasser1, Joseph Renzulli, George A Turini, George Haleblian, Harry C Sax, Gyan Pareek.   

Abstract

OBJECTIVES: To analyze and classified our single-institution experience with the perioperative complications associated with robot-assisted laparoscopic radical prostatectomy (RALRP).
METHODS: A total of 239 patients with a mean age of 60.6 years were evaluated (January 2007 to June 2008). Data were collected through an institutional review board-approved blinded prospective database by an independent third party committee. The data-points accrued were set forth by a 5-member panel including 3 robotic urological surgeons (J. R., G. H., G. P.), the chief of general surgery (H. S.), and a member of the hospital's outcomes committee. The Modified Clavien system was used to grade complications, with grade I and II representing minor and grade III, IV, and V major complications.
RESULTS: Of our 239 patients, 198 (82.9%) had an uneventful postoperative course, defined as discharged home from the hospital within 2 days postoperatively with no unscheduled procedures/studies/hospital admissions or emergency room visits. On review of the remaining 41 patients, 55 complications were found. Of these, 24 were grade I, 17 grade II, 7 grade IIIa, 5 grade IIIb, 1 grade IVa, and 1 grade V complications. There was 1 perioperative mortality (0.4%) attributed to a pulmonary embolism on autopsy. Blood loss data revealed 1 (0.4%) intraoperative transfusion and 9 (3.8%) postoperative transfusions.
CONCLUSIONS: RALRP is associated with major and minor complication rates of 5.0% and 14.6%, respectively. Prospective and blinded data on complications associated with RALRP are lacking in the published data. Our prospective, unbiased data provide an important tool to help counsel patients on complications associated with robot-assisted laparoscopic radical prostatectomy. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20110114     DOI: 10.1016/j.urology.2009.09.082

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

Review 1.  Avoiding and managing vascular injury during robotic-assisted radical prostatectomy.

Authors:  René Sotelo; Luciano A Nunez Bragayrac; Victor Machuca; Roberto Garza Cortes; Raed A Azhar
Journal:  Ther Adv Urol       Date:  2015-02

Review 2.  Robotic surgery in urologic oncology: gathering the evidence.

Authors:  Ted A Skolarus; Yun Zhang; Brent K Hollenbeck
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2010-08       Impact factor: 2.217

Review 3.  Does robotic prostatectomy meet its promise in the management of prostate cancer?

Authors:  Kuo-How Huang; Stacey C Carter; Jim C Hu
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

4.  Radical retropubic prostatectomy: comparison of the open and robotic approaches for treatment of prostate cancer.

Authors:  Jeffrey J Tosoian; Stacy Loeb
Journal:  Rev Urol       Date:  2012

5.  Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.

Authors:  Ryuta Tanimoto; Yomi Fashola; Kymora B Scotland; Anne E Calvaresi; Leonard G Gomella; Edouard J Trabulsi; Costas D Lallas
Journal:  BMC Urol       Date:  2015-04-08       Impact factor: 2.264

6.  Multidetector CT imaging of post-robot-assisted laparoscopic radical prostatectomy complications.

Authors:  Massimo Tonolini; Federica Villa; Roberto Bianco
Journal:  Insights Imaging       Date:  2013-09-10

7.  Dedicated robotics team reduces pre-surgical preparation time.

Authors:  Michael S Lasser; Chintan K Patel; Sammy E Elsamra; Joseph F Renzulli; George E Haleblian; Gyan Pareek
Journal:  Indian J Urol       Date:  2012-07

Review 8.  Surgical complications of laparoscopic urological surgery.

Authors:  Michael S Lasser; Reza Ghavamian
Journal:  Arab J Urol       Date:  2012-01-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.